REQUEST A DEMO
Total
USD $0.00
Search more companies

Tulsi Biosciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tulsi Biosciences Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Tulsi Biosciences Private Limited is an unlisted company, incorporated on 01/06/2009. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2009PTC057124 and registration number is 057124. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No. 57-1, 1St Phase, Gidc, Vapi
Valsad; Gujarat; Postal Code: 396195

Contact Details: Purchase the Tulsi Biosciences Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Tulsi Biosciences Private Limited report to view the information.
Outstanding Shares:
Purchase the Tulsi Biosciences Private Limited report to view the information.
Registered Capital:
Purchase the Tulsi Biosciences Private Limited report to view the information.
Incorporation Date:
June 01, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
61.2%
Purchase this report to view the information.
8.2%
Company Performance
Financial values in the chart are available after Tulsi Biosciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.24%
Total operating revenue
-4.06%
Operating profit (EBIT)
-56.47%
EBITDA
-49.24%
Net Profit (Loss) for the Period
-57.82%
Total assets
49.06%
Total equity
14.81%
Operating Profit Margin (ROS)
-3.45%
Net Profit Margin
-2.78%
Return on Equity (ROE)
-22.22%
Debt to Equity Ratio
55.67%
Quick Ratio
-0.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?